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Objectives: To prospectively document the incidence, location, risk factors for and clinical consequences of restenosis after
carotid artery angioplasty and stenting (CAS).
Methods: Serial duplex and neurological examinations were performed in 217 patients one day (n 216), 3 (n 189), 12
(n 129) and 24 (n 48) months, after CAS. The relationship between patient, lesion and procedure variables and
restenosis was determined at 12 months.
Results: The prevalence of restenosis  50% was 14, 16, 18, and 21%, respectively, and was only significantly related with
loss of proximal stent apposition (odds ratio 3.4, 95% confidence interval: 1.0±11.7, p5 0.05). Four restenoses were
symptomatic.
Conclusions: Restenosis after CAS is common, unpredictable but infrequently symptomatic.
Keywords: CAS; Restenosis; Duplex ultrasonography; Follow-up.
Introduction
Carotid angioplasty and stenting (CAS) may offer a
number of theoretical and practical advantages over
carotid endarterectomy (CEA), especially in high risk
patients with inaccessible lesions.1±7 Although con-
trolled data suggest that CAS is as safe as CEA in the
short-term, there remain concerns over its durability
as a means of stroke prevention, primarily because of
restenosis.8±13 The aims of the present study were to
prospectively document the incidence, location, risk
factors for and clinical consequences of restenosis
after CAS.
Methods
Written informed consent was obtained from 217
patients with symptomatic (56 months) 470%
(NASCET) or asymptomatic (pre-CABG, restenosis
after CEA) 490% internal carotid artery (ICA) sten-
osis who underwent serial duplex (HP/Agilent, Sonos
2500 or 4500, Andover, USA)14±16 and independent
neurological examinations one day (n 216), 3
(n 189) 12 (n 129) and 24 (n 48) months, after
unilateral CAS. Exclusion criteria included major
stroke, stent placement in the common carotid artery
(CCA) only, placement of multiple stents, and unsuc-
cessful stenting, defined as failure to place the stent at
the desired site because of tortuosity of the aorta or
aortic arch branches or inability to cross the lesion
with a wire. The relationship between patient, lesion
and procedure variables and restenosis was deter-
mined at 12 months. CAS was performed via retro-
grade femoral access under local anaesthesia using
continuous ECG and blood pressure monitoring. In
some patients a prophylactic external pacemaker was
placed. Aspirin (38±100 mg/day) was given prior to
CAS and continued indefinitely. Clopidogrel (75 mg/
day) was started 72 h before the procedure and con-
tinued for 2±4 weeks. Heparin (5±10,000 IU) and atro-
pine sulphate (0.5±1.0 mg) was given during the
procedure. Passage of a self-expandable stent was
facilitated by predilatation. Following deployment, 5
or 6 mm (2±4 cm length) high-pressure (8±14 atmo-
spheres) balloon angioplasty was performed at the
point of any residual stenosis. Angiographic success
was defined as 530% residual diameter stenosis.
Proximal and distal stent apposition was evaluated
by duplex scanning on the first post-operative day.
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Mean duplex follow-up was 11 months (range 3±36
months, SD 9.5 months). Data were expressed as
mean SD for continuous variables and as percen-
tages for discrete variables. The association between
restenosis at 12 months and various patient, lesion,
and procedure related variables was quantified by
univariate logistic regression analysis. For these ana-
lyses, all continuous variables (age, length, thickness,
and `volume') were dichotomised (cut-off points at
50% of frequency distribution). A p value 50.05 was
considered as statistically significant. The odds ratio
(OR) was used as a measure of association. The 95%
confidence intervals (CI) were computed as a measure
of precision. Non-parametric chi-square analyses were
performed to test the statistical significance of the site
of in-stent restenosis.
Results
There was a high proportion of pre-CABG and high-
risk patients (Table 1). One patient died on the first
post-operative day due to groin haemorrhage. Duplex
data are given in Tables 2 and 3. Although residual
stenosis was observed on duplex on the first post-
operative day in 31 patients, subsequent angiography
confirmed residual stenosis of 430% in only three. At
3 months, one patient had an occluded stent and an
ipsilateral transient ischaemic attack (TIA). Severe
restenosis (90±99%) occurred in five patients at
3 months. Of these, two were treated conservatively.
In one the lesion reversed to a 65±89% stenosis at
12 months and remained stable during further
follow-up. In the other patient the degree of restenosis
did not change. Both patients were asymptomatic at
2 years follow-up. The third patient with severe rest-
enosis had an ipsilateral TIA and underwent success-
ful CEA. The fourth patient remained asymptomatic
and underwent balloon angioplasty without restent-
ing resulting in a residual stenosis of 50% at day one,
and of 65±89% at 3 months. Finally, the fifth patient
remained asymptomatic but died of lung cancer. At
12 months follow-up, there was one additional asymp-
tomatic patient with a severe restenosis (90±99%), and
one patient with amaurosis fugax and a restenosis of
65±89% but arteriographically a stenosis of 90±99%.
These two patients also underwent CEA with good
surgical results. Four of the eight described patients
with severe restenosis or occlusion had a (re)stenosis
(50%) at day one: 3 patients a 65±89%, and one
patient a 50±64% stenosis. None of these patients had
restenosis after previous CEA. Additionally to the
above described patients with a progressive severe
restenosis, 15 patients showed a 65±89%, and 33
patients a 50±64% restenosis somewhere during
Table 1. Patient characteristics.
N %
Patient characteristics
Age (year, mean SD) 70 8.2
Men 155 71
Symptomatic 51 24
Previous ipsilateral CEA 10 5
Lesion characteristics
Preprocedural stenosis
65±89% 32 14
90±99% 185 86
Length stenosis (mm, mean SD) 22.8 8.6
`Volume' stenosis (mm2, mean SD) 110.3 54.6
Procedure characteristics
Stent type
Easy wall 83 38
Carotid wall 134 62
ECA overstented 182 84
Loss of proximal apposition 27 12
Loss of distal apposition 15 7
Table 3. Site of restenosis.
Site of restenosis n
Day 1
(N 31)
3 months
(N 30)
12 months
(N 23)
24 months
(N 10)
Proximal body
of the stent
0 1 1 0
Central body
of the stent
22 24 21 9
Distal body
of the stent
8 4 1 0
Distal ICA 1 1 0 1
p-value 0.0001 0.0001 0.0001 0.0001
ICA, internal carotid artery.Restenosis in the ICA distal to the stent.
Table 2. Restenosis following CAS.
Stenosis (%) n
Day 1
(N 216)
3 months
(N 189)
12 months
(N 129)
24 months
(N 48)
0±49 185 159 106 38
50±64 23 15 9 5
65±89 8 9 1 4
90±99 0 5y 2z 1
Occlusion 0 1 1 0x
CEA, Carotid endarterectomy; PTA, Percutaneous transluminal
angioplasty; Afx, Amaurosis Fugax.One patient underwent CEA because of Afx and arteriographically
a 90±99% stenosis.
yOne patient received CEA, one re-PTA, one died of lung cancer,
one reversed to 65±89%, one remained asymptomatic with 90±99%
stenosis at 2-year follow-up.
zOne patient underwent CEA.
xPatient with occlusion at 3 months had no follow-up at 24 months
yet. Patients who died or underwent CEA were lost to follow-up.
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follow-up. Clinical follow-up in these 48 patients
revealed only one minor stroke in the latter group. In
summary, with a mean neurological follow-up of 13
months (range 3±36 months, SD 9.5 months) 4 of 56
patients (7%) with restenosis on duplex scan became
symptomatic. Two of these patients underwent CAS
for a symptomatic and two for an asymptomatic ICA
stenosis. Restenosis was only significantly associated
with loss of proximal stent apposition (OR 3.4, 95% CI
1.0±11.7, p5 0.05).
Discussion
In the present study, restenosis after CAS was com-
mon, located mainly the central body of the stent,
related only to loss of proximal stent apposition and
symptomatic in 7% (three during the first year and
one during the second). This is a considerably higher
rate of restenosis than has been reported in most other
series (2±8%), with the exception of the CAVATAS trial
where, it was 22% at 1 year.10,17±26 However, the accur-
acy of duplex in the assessment of post-CAS restenosis
is unknown27±29 as is its role in plaque characterisa-
tion.30±33 In conclusion, using generally accepted vel-
ocity criteria for the examination of native carotid
artery lesions we found a high percentage of resteno-
sis after CAS. However, the use of duplex ultrasono-
graphy in follow-up studies after CAS is still in
evolution and the determination of its reliability will
have to wait for results in series with sufficient posi-
tive outcomes at MR angiography, spiral CT scanning
or three-dimensional rotation arteriography. Lastly,
the development of restenosis appears to be unpre-
dictable, as is its propensity to cause symptoms.
Larger studies are required to address these questions.
Appendix
Members of the Antonius Carotid Endarterectomy,
Angioplasty, and Stenting Study Group:
Department of CardiologyÐJ.M.P.G. Ernst, MD,
PhD; M.J. Suttorp, MD, PhD; J.M ten Berg, MD, PhD;
M.S. Zwarts, MD.
Department of Cardiothoracic SurgeryÐK.M.E.
Dossche, MD, PhD; W.J. Morshuis, MD, PhD;
M.A.A.M. Schepens, MD, PhD.
Department of Clinical NeurophysiologyÐR.G.A.
Ackerstaff, MD, PhD; M.H. Christiaans, MD; E.S.
Louwerse, MD, PhD; I.C. van der Schaaf, MD.
Department of NeurologyÐH.W. Mauser, MD,
PhD; O.J.M. Vogels, MD, PhD.
Department of RadiologyÐJ.C. van den Berg, MD,
PhD; J.P.M. van Heesewijk, MD, PhD; T.Th.C.
Overtoom, MD; J.A. Vos, MD.
Department of Research and DevelopmentÐ
J.C. Kelder, MD, Epidemiologist, A.J. Six, MD, PhD.
Department of Vascular SurgeryÐF.L. Moll, MD,
PhD; H.D.W.M. van de Pavoordt, MD, PhD.
References
1 North American Symptomatic Carotid Endarterectomy
Trial Collaborators. Beneficial effect of carotid endarterec-
tomy in symptomatic patients with high-grade carotid stenosis.
N Engl J Med 1991; 325: 445±453.
2 Barnett HJM, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG,
Haynes RB, Rankin RN, Clagett GP, Hachinski VC,
Sackett DL, Thorpe KE, Meldrum HE, The North American
Symptomatic Carotid Endarterectomy Trial
Collaborators. Benefit of carotid endarterectomy in patients
with symptomatic moderate or severe stenosis. N Engl J Med
1998; 339: 1415±1425.
3 European Carotid Surgery Trialists' Collaborative Group.
Randomised trial of endarterectomy for recently symptomatic
carotid stenosis: final results of the MRC European Carotid
Surgery Trial (ECST). Lancet 1998; 351: 1379±1387.
4 Executive Committee for the Asymptomatic Carotid
Atherosclerosis Study. Endarterectomy for asymptomatic
carotid artery stenosis. JAMA 1995; 273: 1421±1428.
5 Roubin GS, New G, Ier SS, Vitek JJ, Al-Mubarak N, Liu MW,
Yadav J, Gomez C, Kunt RE. Immediate and late clinical out-
comes of carotid artery stenting in patients with symptomatic
and asymptomatic carotid artery stenosis. A 5-year prospective
analysis. Circulation 2001; 103: 532±537.
6 Vitek J, Iyer S, Roubin G. Carotid stenting in 350 vessels: pro-
blems faced and solved. J Invasive Cardiol 1998; 10: 311±314.
7 Yadav JS, Roubin GS, Iyer S, Vitek J, King P, Jordan WD,
Fisher WS. Elective stenting of the extracranial carotid arteries.
Circulation 1997; 95: 376±381.
8 Diethrich EB, Ndiaye M, Reid D. Stenting in the carotid artery:
initial experience in 110 patients. J Endovasc Surg 1996; 3: 42±62.
9 Theron JG, Payelle GG, Coskun O, Huet HF, Guimaraens L.
Carotid artery stenosis: treatment with protected balloon angio-
plasty and stent placement. Radiology 1996; 201: 627±636.
10 Wholey MH, Wholey M, Mathias K, Roubin GS,
Diethrich EB, Henry M, Bailey S, Bergeron P, Dorros G,
Eles G, Gaines P, Gomez CR, Gray B, Guimaraens J,
Higashida R, Sai Wah Ho D, Katzen B, Kambara A,
Kuamar V, Laborde JC, Leon M, Lim M, Londero H, Mesa J,
Musacchio A, Myla S, Ramee S, Rodrigues A, Rosenfield K,
Sakai N, Shawl F, Sievert H, Teitelbaum G, Theron JG,
Vaclav P, Vozzi C, Yadav JS, Yoshimura S-I. Global experience
in cervical carotid artery stent placement. Catheter Cardiovasc
Interv 2000; 50: 160±167.
11 Chakhtoura EY, Hobson RW, Goldstein J, Simonian GT,
Lal BK, Haser PB, Silva MB, Padberg FT, Pappas PJ, Jamil Z.
In-stent restenosis after carotid angioplasty-stenting: incidence
and management. J Vasc Surg 2001; 33: 220±226.
12 Paniagua D, Howell M, Strickman N, Velasco J,
Dougherty K, Skolkin M, Toombs B, Krajcer Z. Outcomes
following extracranial carotid artery stenting in high-risk
patients. J Invasive Cardiol 2001; 13: 375±381.
13 Berkefeld J, Turowski B, Dietz A, Lanfermann H, Sitzer M,
Schmitz-Rixen T, Steinmetz H, Zanella FE. Recanalization
results after carotid stent placement. Am J Neuroradiol 2002; 23:
113±120.
14 Moneta GL, Edwards JM, Papanicolaou G, Hatsukami T,
Taylor LM, Strandness DE. Screening for asymptomatic
Restenosis after Carotid Stenting 143
Eur J Vasc Endovasc Surg Vol 26, August 2003
internal carotid artery stenosis: duplex criteria for discriminating
60% to 99% stenosis. J Vasc Surg 1995; 21: 989±994.
15 Moneta GL, Edwards JM, Chitwood RW, Taylor LM, Lee RW,
Cummings CA, Porter JM. Correlation of North American
Symptomatic Carotid Endarterectomy Trial (NASCET) angio-
graphic definition of 70% to 90% internal carotid artery stenosis
with duplex scanning. J Vasc Surg 1993; 17: 152±159.
16 Carpenter JP, Lexa FJ, Davis JT. Determination of sixty percent
or greater carotid artery stenosis by duplex Doppler ultrasono-
graphy. J Vasc Surg 1995; 22: 697±705.
17 Willfort-Ehringer A, Ahmadi R, Gschwandtner ME,
Haumer M, Lang W, Minar E. Single-center experience with
carotid stent restenosis. J Endovasc Ther 2002; 9: 299±307.
18 Bergeron P, Bafort AC, Pietri PA, Khanoyan P, Taube E,
Gay J. Long term results of carotid angioplasty and stenting.
In: Amor M, Bergeron P, Mathias K, Raithel D, eds. Carotid Artery
Anguioplasty and Stenting. A Multidisciplinary Approach. Torino:
Edizioni Minerva Medica 2002; 246±253.
19 Bonaldi G. Angioplasty and stenting of the cervical carotid
bifurcation: report of a 4-year series. Neuroradiology 2002; 44:
164±174.
20 Kao H-L, Lin L-Y, Lu C-J, Jeng J-S, Yip P-K, Lee Y-T. Long-term
results of elective stenting for severe carotid artery stenosis in
Taiwan. Cardiology 2002; 97: 89±93.
21 CAVATAS investigators Endovascular versus surgical treatment
in patients with carotid stenosis in the Carotid and vertebral
Artery Transluminal Angioplasty Study (CAVATAS): a rando-
mized trial. Lancet 2001; 357: 1729±1737.
22 Gray BH, Sullivan TM, Childs MB, Young JR, Olin JW. High
incidence of restenosis/reocclusion of stents in the peripheral
treatment of long-segment superficial femoral artery disease
after suboptimal angioplasty. J Vasc Surg 1997; 25: 74±83.
23 Kobayashi Y, Gregorio JD, Kobayashi N, Akiyama T,
Reimers B, Finci L, Mario CD, Colombo A. Stented segment
length as an independent predictor of restenosis. J Am Coll
Cardiol 1999; 34: 651±659.
24 Elezi S, Kastrati A, Neumann F-J, Hadamitzky M,
Dirschinger J, SchoÈ mig A. Vessel size and long-term outcome
after coronary stent placement. Circulation 1998; 98: 1875±1880.
25 Kastrati A, Elezi S, Dirschinger J, Hadamitzky M,
Neumann F-J, SchoÈ mig A. Influence of lesion length on rest-
enosis after coronary stent placement. Am J Cardiol 1999; 83:
1617±1622.
26 Kastrati A, Mehilli J, Dirschinger J, Dotzer F, SchuÈ hlen H,
Neumann F-J, Fleckenstein M, Pfafferot C, Seyfarth M,
SchoÈ mig A. Intracoronary stenting and angiographic results.
Strut thickness effect on restenosis outcome (ISAR-STEREO)
trial. Circulation 2001; 103: 2816±2821.
27 Robbin ML, Lockhart ME, Weber TM, Vitek JJ, Smith JK,
Yadav J, Mathur A, Iyer SS, Roubin GS. Carotid artery stents:
early and intermediate follow-up with Doppler US. Radiology
1997; 205: 749±756.
28 Ringer AJ, German JW, Guterman LR, Hopkins LN. Follow-up
of stented carotid arteries by Doppler ultrasound. Neurosurgery
2002; 51: 639±643.
29 Berry JL, Manoach E, Mekkaoui CH, Rolland PH, Moore JE,
Rachev A. Hemodynamics and wall mechanics of a compliance
matching stent: in vitro and in vivo analysis. J Vasc Interv Radiol
2002; 13: 97±105.
30 Biasi GM, Mingazzinni PM, Ferrari SA, Elatrozy TS,
Nicolaides AN. Characterization of carotid plaque for the iden-
tification of angioplasty and stenting: the ICAROS registry. CVI
on-line 1999; 4: 12±13.
31 Sabetai MM, Tegos TJ, Nicolaides AN, El Atrozy TS,
Dhanjil S, Griffin M, Belcaro G, Geroulakos G. Hemi-
spheric symptoms and carotid plaque echomorphology. J Vasc
Surg 2000; 31: 39±49.
32 Sabetai MM, Tegos TJ, Nicolaides AN, Dhanjil S, Pare GJ,
Stevens JM. Reproducibility of computer-quantified carotid
plaque echogenecity. Can we overcome the subjectivity?. Stroke
2000; 31: 2189±2196.
33 Nicolaides AN. Asymptomatic carotid artery stenoses and risk
of stroke. Identification of a high risk group (ACRS). A natural
history study. Int Angiol 1995; 14: 21±23.
Accepted 14 April 2003
144 M. H. Christiaans et al.
Eur J Vasc Endovasc Surg Vol 26, August 2003
